Revvity | PKI - Коммерческие и административные расходы





Коммерческие и административные расходы Изменить Дата
Agilent USD 465M 11M 2026-03
Align Technology USD 465.34M 23.67M 2026-03
Bio Techne USD 109.34M 4.35M 2026-03
Bio-Rad Laboratories USD 221M 14.2M 2025-12
Bruker USD 242.1M 5.1M 2026-03
Celltrion KRW 12.71B 237.27B 2025-12
Charles River Laboratories USD 159.42M 36.71M 2026-03
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 351M 32M 2026-03
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Illumina USD 272M 11M 2026-03
Intuitive Surgical USD 613.3M 73.8M 2026-03
IQVIA Holdings USD 502M 34M 2026-03
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Laboratory Of America USD 551M 12.4M 2026-03
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Mesa Laboratories USD 27.31M 380K 2024-09
Mettler Toledo International USD 258.33M 1.5M 2026-03
Myriad Genetics USD 122.3M 6.7M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Ovoca Bio EUR 632K 2.33M 2025-06
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Pharma Mar EUR 15.31M 2M 2026-03
Qiagen NV USD 153.88M 10.77M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Quidel USD 199.3M 4.9M 2026-03
Repligen USD 76.54M 2.17M 2026-03
Revvity USD 253.88M 2.15M 2026-03
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Tilray USD 24.85M 1.7M 2025-09
Waters USD 394M 153.99M 2026-03
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03